PPT-Migraine Other pharmacological treatments

A source of some controversy certain opioids are recommended in some guidelines eg by the American Headache Society 4 but advised against in others eg by Canadian Headache Society and European Headache Federation. Goetz MD Werner Poewe MD Olivier Rascol MD PhD and Cristina Sampaio MD PhD Department of Neurological Sciences Department of Pharmacology Rush University Medical Center Chicago Illinois USA Department of Neurology Innsbruck Medical University Innsbr Bystritsky is Professor of Psychiatry and Biobehavioral Sciences and Director of Anxiety and Treatmentresistant OCD Program Neuropsychiatric Institute David Geffen School of Medicine University of California Los Angeles Introduction ObsessiveCompuls 2012 American Academy of Neurology www.aan.comAAN Member Services at (800) 879-1960. Several herbal preparations, vitamins, and minerals are used for preventing migraine. Strong evidence shows that th The expanding border is often described as “shimmering” or associated with “zig-zag” lines, “heat waves,” or “sparklers.” While most frequently followed by a Current Pharmacological Treatments for Obsessive-Compulsive DisorderAlexander Bystritsky, MDDr. Bystritsky is Professor of Psychiatry and Biobehavioral Sciences and Director of Anxiety and Treatment-r Quelques concepts pratico-pratiques. Dr Elizabeth Leroux, . MD . FRCPC . Neurologue, CHUM. Congrès de l’Association des Gynécologues-Obstétriciens du Québec . Gatineau. Mai 2016 . Conflits d’intérêt. Christopher S Calder MD PhD. Interim Chair Neurology . Associate . P. rofessor UNM Neurology. Conflicts of Interest. I have headaches, literal and figuratively!. I have be an investigator in many clinical trials in the past. . AMG334 /Aimovig™ . Goadsby. PJ, Reuter U, . Hallström. Y, . Broessner. G, Bonner JH, Zhang F, . Sapra. S, Picard H, . Mikol. DD, Lenz RA. N . Engl. J Med 2017; 377:2123-2132 November 30, 2017. By Tammy Butler, Pharm.D.. Disclosure . Presenter is not affiliated with any manufacturers of the mentioned products or devices in this presentation. . Objectives. Learning Objectives (Pharmacist):. Learning Objectives (Pharmacy Technician):. Migraine Headaches:   Did You Know? By Tammy Butler, Pharm.D. Disclosure Presenter is not affiliated with any manufacturers of the mentioned products or devices in this presentation. Objectives Learning Objectives (Pharmacist): Britt Schloemer, APRN . 2018 KY NAPNAP Annual Update. Objectives. Describe what a migraine is. Present an update on acute migraine treatment recommendations. Discuss treatment options for migraine prevention. CLINICAL CONDITIONS . IN WHICH 5-HT . PLAYS A ROLE . (. carcinoid syndrome and pulmonary . hypertension. .). The . most common types of headaches . are: . migraine, tension-type, . and cluster . headaches.. A person may experience migraine both with and without aura, and the aura experience varies between and within individuals. 1. Compared with migraine without aura, migraine with aura appears to have:. Migraine is a chronic neurological disease with episodic attacks of head pain. 1. If caused by another medical condition, the headache is said to be a secondary headache. 2. Migraine is characterised, including by .